IL128782A0 - Crystalline pharmaceutical product - Google Patents

Crystalline pharmaceutical product

Info

Publication number
IL128782A0
IL128782A0 IL12878297A IL12878297A IL128782A0 IL 128782 A0 IL128782 A0 IL 128782A0 IL 12878297 A IL12878297 A IL 12878297A IL 12878297 A IL12878297 A IL 12878297A IL 128782 A0 IL128782 A0 IL 128782A0
Authority
IL
Israel
Prior art keywords
pharmaceutical product
crystalline pharmaceutical
crystalline
product
pharmaceutical
Prior art date
Application number
IL12878297A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL128782A0 publication Critical patent/IL128782A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12878297A 1996-09-03 1997-08-29 Crystalline pharmaceutical product IL128782A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2536996P 1996-09-03 1996-09-03
PCT/US1997/015292 WO1998009629A1 (fr) 1996-09-03 1997-08-29 Produit pharmaceutique cristallin

Publications (1)

Publication Number Publication Date
IL128782A0 true IL128782A0 (en) 2000-01-31

Family

ID=21825633

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12878297A IL128782A0 (en) 1996-09-03 1997-08-29 Crystalline pharmaceutical product

Country Status (32)

Country Link
US (1) US6335330B1 (fr)
EP (1) EP0964684B1 (fr)
JP (1) JP2000517342A (fr)
CN (1) CN1102391C (fr)
AP (1) AP9901472A0 (fr)
AR (1) AR008154A1 (fr)
AT (1) ATE245984T1 (fr)
AU (1) AU731173B2 (fr)
BG (1) BG103196A (fr)
BR (1) BR9711981A (fr)
CA (1) CA2264607A1 (fr)
CO (1) CO4930262A1 (fr)
CZ (1) CZ71999A3 (fr)
DE (1) DE69723873T2 (fr)
DZ (1) DZ2302A1 (fr)
EA (1) EA001363B1 (fr)
ES (1) ES2205254T3 (fr)
HU (1) HUP9904077A3 (fr)
ID (1) ID18156A (fr)
IL (1) IL128782A0 (fr)
MA (1) MA24309A1 (fr)
MY (1) MY118175A (fr)
NO (1) NO991013L (fr)
NZ (1) NZ334438A (fr)
OA (1) OA10986A (fr)
PE (1) PE107198A1 (fr)
PL (1) PL332006A1 (fr)
SK (1) SK27699A3 (fr)
TR (1) TR199900480T2 (fr)
UY (1) UY24690A1 (fr)
WO (1) WO1998009629A1 (fr)
ZA (1) ZA977870B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19902529A1 (de) * 1999-01-22 2000-08-03 Goldwell Gmbh Haarbehandlungsmittel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
EP1443963B1 (fr) 2001-10-22 2014-05-21 The Scripps Research Institute Composes de ciblage d'anticorps
US20050202151A1 (en) * 2004-03-15 2005-09-15 Land O'lakes, Inc. Method of preparing egg nuggets
KR101046977B1 (ko) * 2004-11-15 2011-07-07 삼성에스디아이 주식회사 카본나노튜브, 이를 포함한 전자 방출원 및 이를 구비한전자 방출 소자
WO2007048127A2 (fr) * 2005-10-20 2007-04-26 The Scripps Research Institute MARQUAGE DE PARTIES Fc POUR L'IMMUNOCOLORATION ET L'IMMUNOCIBLAGE
EP2395992A2 (fr) 2009-02-10 2011-12-21 The Scripps Research Institute Vaccination programmée chimiquement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138319A1 (de) * 1978-08-08 1979-10-24 Helmut Roehnert Verfahren zur herstellung einer stabilen,kristallwasser-und kristalloesungsmittelfreien kristallform des 7-chlor-2-methylamino-5-phenyl-3h-1,4-benzodiazepin-4-oxid-hydrochlorids
AU666318B2 (en) 1991-06-28 1996-02-08 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5939412A (en) 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
NZ314922A (en) 1992-12-21 1998-11-25 Smithkline Beecham Corp Benzodiazepinones; nitrogen containing heterocyclic intermediates and pharmaceutical compositions
MA23420A1 (fr) 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.

Also Published As

Publication number Publication date
DE69723873D1 (de) 2003-09-04
AU731173B2 (en) 2001-03-22
DZ2302A1 (fr) 2002-12-28
CA2264607A1 (fr) 1998-03-12
UY24690A1 (es) 1998-02-27
NZ334438A (en) 2000-10-27
BR9711981A (pt) 1999-08-24
EP0964684A4 (fr) 2002-05-29
EA001363B1 (ru) 2001-02-26
US6335330B1 (en) 2002-01-01
ID18156A (id) 1998-03-05
ATE245984T1 (de) 2003-08-15
PL332006A1 (en) 1999-08-16
ZA977870B (en) 1998-03-03
BG103196A (en) 1999-09-30
WO1998009629A1 (fr) 1998-03-12
CZ71999A3 (cs) 1999-08-11
DE69723873T2 (de) 2004-04-22
AR008154A1 (es) 1999-12-09
EP0964684A1 (fr) 1999-12-22
HUP9904077A3 (en) 2002-03-28
AP9901472A0 (en) 1999-03-31
CO4930262A1 (es) 2000-06-27
NO991013D0 (no) 1999-03-02
EP0964684B1 (fr) 2003-07-30
MY118175A (en) 2004-09-30
TR199900480T2 (xx) 1999-06-21
ES2205254T3 (es) 2004-05-01
CN1234739A (zh) 1999-11-10
HUP9904077A2 (hu) 2000-05-28
NO991013L (no) 1999-03-02
CN1102391C (zh) 2003-03-05
JP2000517342A (ja) 2000-12-26
MA24309A1 (fr) 1998-04-01
PE107198A1 (es) 1999-03-21
OA10986A (en) 2003-03-04
EA199900260A1 (ru) 1999-08-26
SK27699A3 (en) 2000-02-14
AU4242597A (en) 1998-03-26

Similar Documents

Publication Publication Date Title
EG23763A (en) Novel pharmaceutical product
GB9602080D0 (en) Pharmaceutical compounds
IL116913A0 (en) Novel pharmaceutical combination
ZA957753B (en) Novel pharmaceutical product
GB9610862D0 (en) Pharmaceutical products
GB9801538D0 (en) Pharmaceutical product
GB9609976D0 (en) Pharmaceutical compounds
GB9621789D0 (en) Pharmaceutical compounds
GB9505524D0 (en) Product
IL128782A0 (en) Crystalline pharmaceutical product
ZA979329B (en) Pharmaceutical compounds
GB9619894D0 (en) Pharmaceutical products
AU126984S (en) Pharmaceutical product
GB9626151D0 (en) Pharmaceutical compounds
GB9514252D0 (en) Mouldable product
GB9513762D0 (en) Product
GB9612684D0 (en) Pharmaceutical products
HK1025734A (zh) 晶状药用产品
GB9413859D0 (en) Pharmaceutical products
GB9620834D0 (en) Pharmaceutical products
GB9620465D0 (en) Pharmaceutical products
SG32504A1 (en) Novel pharmaceutical product
ZA968431B (en) Pharmaceutical product
GB9624891D0 (en) Product
GB9624919D0 (en) Product